GB2248061A - Amino-hydroxy-alkylidene bis phosphonic acids - Google Patents

Amino-hydroxy-alkylidene bis phosphonic acids Download PDF

Info

Publication number
GB2248061A
GB2248061A GB9119201A GB9119201A GB2248061A GB 2248061 A GB2248061 A GB 2248061A GB 9119201 A GB9119201 A GB 9119201A GB 9119201 A GB9119201 A GB 9119201A GB 2248061 A GB2248061 A GB 2248061A
Authority
GB
United Kingdom
Prior art keywords
acid
temperature
range
alkyl
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB9119201A
Other versions
GB9119201D0 (en
Inventor
Gerard R Kieczykowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of GB9119201D0 publication Critical patent/GB9119201D0/en
Publication of GB2248061A publication Critical patent/GB2248061A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/5537Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom the heteroring containing the structure -C(=O)-N-C(=O)- (both carbon atoms belong to the heteroring)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • C07F9/3873Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)

Abstract

A process for producing omega -amino-1-hydroxybutylidene-1, 1-bisphosphonic acids (e.g. ABP), useful as antihypercalcemic agents, involves a 3-step sequence starting with 4-phthalimidobutanoyl chloride which can be practiced as a "one-pot" reaction sequence, without employing PCl3 or H3PO3. Intermediates in the process are dialkyl omega -phthalimido alkanoyl phosphonates and tetra-alkyl- omega -phthalimido-1-hydroxy alkylidene-bis-phosphonates.

Description

TITLE OF THE INVENTION NEW PROCESS FOR PREPARING AN ANTIHYPERCALCEMIC AGENT BACKGROUND OF THE INVENTION 4-Amino-l-hydroxybutylidene-l,l-bisphosphonic acid (ABP), and salts thereof, is a new antihypercalcemic agent effective in the treatment or prevention of diseases involving hypercalcemia of pregnancy, Pages disease and osteoporosis.
Methods for preparing ABP are known in the art and are disclosed in U.S. Patent 4,407,761 to Henkel and U.S. Patent 4,922,007 to G.R. Kiecykowski et al (assigned to Merck & Co., Inc.). However, these methods employ the use of toxic and environmentally dangerous phosphorus trichloride and phosphorous acid in their procedures. Newer methods which do not employ these particularly hazardous and toxic reagents are constantly being searched for.
The articles, . Org. Chem. Vol. 36, No. 24, pp 3843-45 (1971) and . Med. Chem. 1987, Vol. 30, pp. 1426-1433, describe general methods of preparation of tetramethylalkyl-l-hydroxy-l,l-diphosphonates but do not specifically describe the preparation of omega-amino-l-hydroxyalkyl diphosphonates.
The use of the phthaloyl protecting group in amino acid chemistry is well known, e.g., J. Med.
Chem. 1979, vol. 22, No. 11, pp. 1399-1402, but there is no specific teaching as to their possible use in preparing omega-amino-l-hydroalkyl diphsophonates.
SUMMARY OF THE INVENTION It has been found that ABP can be produced in good yield via a novel process that does not employ PC13 or H3P03. The process involves reacting 4-phthalimidobutanoyl chloride with a tri C1-C4 alkylphosphite, e.g., trimethyl phosphite, and then with a di C1-C4 alkylphosphite, e.g., dimethyl phosphite, to form the tetraalkyl ester, e.g., tetramethyl bisphosphonate, which is then acid hydrolyzed to form ABP in good yield and purity.
In addition, the process is applicable to the preparation of other omega-amino-l-hydroxy-C2-C6 alkyl disphosphonates as well.
By this invention there is provided a process for producing omega-amino-l-hydroxy-C2-C6 alkylidene-bisphosphonic acid comprising the steps of: (a) contacting omega-phthalimido C2-C6 alkanoyl chloride with a tri C1-C4 alkyl phosphite in a dry inert organic solvent at a temperature in the range of O to 60"C to form di C1-C4 alkyl omega-phthalimido-C2-C6 alkanoyl phosphonate; (b) contacting di C1-C4 alkyl omegaphthalimido-C2-C6 alkanoyl phosphonate from Step (a) with di C1-C4 alkyl phosphite in a dry inert organic solvent in the temperature range of O to 60"C to form tetra C1-C4 alkyl omega-phthalimido-l-hydroxy-C2-C6 alkylidene-bisphosphonate;; (c) contacting tetra C1-C4 alkyl omegaphthalimido-l-hydroxy-C2-C6 alkylidene-bisphosphonate from Step (b) with aqueous strong acid at a temperature in the range of 90"C to reflux to form omegaamino-l-hydroxy-C2-C6 alkylidene-bisphosphonic acid.
Specifically there is provided a process for producing 4-amino-1-hydroxybutylidene-bisphosphonic acid comprising the steps of: (a) contacting 4-phthalimidobutanoyl chloride with trimethyl phosphite in a dry inert organic solvent at a temperature in the range of O to 60"C to form dimethyl 4-phthalimidobutanoyl phosphonate; (b) contacting dimethyl 4-phthalimidobutanoyl phosphonate from Step (a) with dimethyl phosphite in a dry inert organic solvent in the temperature range of O to 60"C to form tetramethyl phthalimido-l-hydroxy butylidene-bisphosphonate; (c) contacting tetramethyl phthalimidol-hydroxybutylidene-bisphosphonate from Step (b) with aqueous hydrochloric acid at a temperature range of 80"C to reflux to form 4-amino-l-hydroxybutylidenebisphosphonic acid.
BRIEF DESCRIPTION OF PREFERRED EMBODIMENTS The invention process can be more readily seen and appreciated by referring to the following Flow Chart 1. This new process for the preparation of ABP can proceed in good overall yield from gamma4-aminobutyric acid (GABA). As depicted in the flow chart, phthalic anhydride is reacted with GABA, e.g.
in acetic acid, to form the known 4-phthalimidobutyric acid 1 which can be isolated by e.g., crystallization from acetic acid-water. It is converted into the known acid chloride Z by reaction with about 1.2 equivalents of thionyl chloride in, e.g. toluene, and without isolation can be converted to the acyl phosphonate 3 with about 1.05 equivalents of trimethyl phosphite. The acyl phosphonate 3 can then be in turn converted, without isolation, into the bisphosphonate 4 by reacting with dimethyl phosphite (in e.g. toluene) in the presence of an amine base, e.g., triethylamine. The bisphosphonate can crystallize as it is formed and can be isolated by filtration in good overall yield.Hydrolysis of the bisphosphonate with a strong aqueous acid, e.g., 6N HC1, provides ABP which can then be converted into the monosodium salt, which is the preferred pharmaceutical dosage form, with sodium hydroxide at about a pH of 4.3, in which the sodium aqueous salt can easily be isolated.
In addition to utilizing 4-aminobutanoic acid, also operable are glycine, 3-aminopropanoic acid, 5-aminopentanoic acid and 6-aminohexanoic acid, which yield the corresponding omega-amino-l-hydroxy C2-C6 alkylbisphosphonates in the invention process, e.g., 2-amino-l-hydroxyethylidene-l,l-bisphosphonic acid, 3-amino-l-hydroxypropylidene-l, 1-bisphosphonic acid, 5-amino-1-hydroxypentylidene-1,1-bisphosphonic acid, 6-amino-l-hydroxy-hexylidene-l,l-bisphosphonic acid.
More detail concerning the individual steps is as follows: FLOW CHART
The 4-phthalimidobutanoic acid is known in the art. The compound can be easily made in our process by for example, reacting phthalic anhydride and aqueous aminobutyric acid in a 1:1 mole ratio in a liquid alkanoic acid, e.g. acetic acid, at about a 40% concentration, at a temperature in the range of 60 to reflux, preferably llO"C, for about 1-4 hours at 1 atmosphere pressure, under anhydrous conditions and then quenching the reaction mixture with water to isolate the resulting acid (1).
The acid chloride (2) also known in the art can easily be made by heating a mixture of the acid (1) with thionyl chloride in a 1:1.2 molar ratio in a dry inert solvent, including C6-C10 aromatic hydrocarbons, chlorinated C6-C1O aromatic hydrocarbons, chlorinated alkyl hydrocarbons, C2-C3 alkylnitriles, C4-C6 linear or cyclic ethers. Representative examples are: toluene, xylene, methylene chloride, chloroform, chlorobenzene, acetonitrile, ethylene dichloride, dichlorohenzene, THF, dioxane, dimethoxyethane, and the like, at a temperature of about 40"C-reflux, preferably 45"C, at atmospheric pressure, under a dry atmosphere, e.g. under nitrogen, for 1-2 hours. The resulting acid chloride does not need to be isolated at this point but can be used directly in the next step by evaporating off the excess thionyl chloride and concentrating the solvent toluene to about one-half its original volume.
Step (a) in the process is conducted by reacting the acid chloride (2) with a tri C1-C4 alkylphosphite, wherein C1-C4 alkyl includes methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, sec-butyl, t-butyl, e.g., trimethyl phosphite. In general, a 1:1.05 molar ratio of acid chloride/trimethylphosphite is used, in which a slight excess of phosphite is employed. The solvent used can be the same as that described above used in forming the acid chloride, e.g. toluene, et al., and preferably the same reaction vessel is employed. The concentration of the reactants is about 5-50% and the reaction is carried out at a temperature of 0-60 C, preferably 20-25"C, in the solvent in a dry atmosphere, e.g.
under nitrogen, for 4-20 hours at atmospheric pressure. The resulting mono-phosphonate (3) does not need to be isolated but can be directly reacted without isolation with dimethylphosphite in Step (b).
The acylphosphonate (3) is next reacted in Step (b) with or without prior isolation, preferably without isolation, with a di C1-C4 alkyl phosphite, wherein "C1-C4 alkyl" is defined above, and preferably dimethylphosphite, in a 1:1.1 molar ratio, the dimethylphosphite being in slight excess, also in the presence of a hydrogen acceptor, e.g. tertiary nitrogen amine. Large amounts of the phosphite can also be used but are not necessary. The amine, preferably a tertiary nitrogen amine, e.g.
trimethylamine, triethylamine, phenyldimethylamine, and the like, is used in a 0.25-1:1 molar ratio of amine/acylphosphonate (3). The inert solvent used in this step can be the same as used for Step (a), e.g.
toluene, methylene chloride, chloroform, and the like, preferably toluene. The temperature for the step is carried out at 0-60"C, preferably 20-25"C, wherein higher temperatures may cause degradation.
The pressure is atmospheric, and the reaction is conducted under a dry atmosphere, e.g. nitrogen, for 1-2 hours and then cooled and filtered to isolate the product. Alternatively, the product can be directly treated in Step (c) with aqueous strong acid in the hydrolysis, but preferably for purity consideration, at this point, the tetramethyl ester (4) is isolated by filtration.
Step (c), the strong acid hydrolysis, is conducted by treating the bisphosphonate (4) with aqueous strong acid at a temperature in the range of 85-100 C to reflux, and preferably at reflux. Strong acids operable in the process are: HC1, H2S04, benzenesulfonic acid, p-toluenesulfonic acid, methanesulfonic acid, HBr, trichloroacetic acid, and the like. Preferably, 6 N HC1 is used. Generally the reaction is conducted from 4-24 hours at reflux at atmospheric pressure. The product can be isolated by the addition of e.g. ethanol, to precipitate the product and the solution.Or preferably, the monosodium salt can be formed in-situ by the addition of aqueous sodium hydroxide to the cooled hydrolysis reaction mixture, sufficient caustic being added to dissolve the acid and produce a pH of about 4.3, allowing the reaction mixture to age for 1 hour, then filtering the monosodium salt. The obtained salt can be used directly or purified by conventional purposes, e.g. recrystallization from water to form suitable material for pharmaceutical purposes.
Apparatus for carrying out the above procedures is conventional in the art.
Also disclosed is the novel general process intermediate compound (III)
where n = 1-5, and the specific intermediate (3),
made by the above process and having the following physical properties described below in the Examples.
Also disclosed is the novel general process intermediate compound (IV)
where n = 1-5, and the specific intermediate (4):
made by the above process and having the above physical properties described below in the Examples.
The following Examples are illustrative of carrying out Applicant's novel process and should not be construed to limit the scope or spirit of Applicants' invention.
EXAMPLE Step 1: Preparation of 4-Phthalimidobutanoic Acid (1) A 2 liter nitrogen flushed flack fitted with a mechanical stirrer and a reflux condenser was charged with 103 g (1 mole) of 4-aminobutyric acid (GABA), 148 g (1 mole) of phthalic anhydride and 250 ml of glacial acetic acid.
The suspension was heated to reflux (120"C) and the resulting clear solution was maintained at reflux for 2 hr. The solution was cooled to 25"C over 1 hr during which time the product crystallized out. Water (1.5 liters) was added over 15 min. and the resulting suspension aged at 5-10 C for 2 hours.
The product was collected by filtration and washed with an additional 0.5 1 of water. The product was vacuum dried (house vac) at 60"C to constant weight yielding 214 g (91.8%, 93% corrected for GABA purity), MP 114-117"C.
Anal. Calcd. For C12 H11 NO: C, 61.80; H, 4.72; N, 6.00; Found: C, 61.78; H, 4.65; N, 5.98.
Step 2: Preparation of 4-Phthalimidobutanoyl Chloride (2) A 250 ml flask flushed and blanketed with nitrogen and fitted with a mechanical stirrer was charged with 23.3 g of 4-phthalimidobutyric acid from Step 1, 100 ml of toluene, 9.0 ml of thionyl chloride and 0.1 ml of DMF. The slurry was agitated gently and warmed to 45-50"C resulting in a clear, colorless solution.
During the age, gentle gas evolution was observed and ceased approximately 1 hour into the age. The excess thionyl chloride was removed by distillation. The volume of the reaction was reduced to 50 ml by distillation under house vacuum (100 mm Hg) and a jacket temperature of 80"C. An additional 100 ml of toluene was added and distilled. The clear, colorless solution was used without purification.
The acid chloride was isolated for characterization as a crystalline solid by concentrating the solution to an oil, adding diethyl ether and filtering, MP 65-68"C.
Anal. Calcd. For C12HloNO3Cl: C, 57.26; H, 3.97; N, 5.56; C1, 14.09; Found: C, 57.48; H, 4.07; N, 5.52; C1, 14.05.
Step 3: Preparation of Dimethyl 4-Phthalimidobutanovl Phosphonate (3) The toluene solution from Step2 containing a theoretical 25.1 g (0.1 mole) of acid chloride was stirred at 20-250C under nitrogen. To this solution was charged 13.0 g (0.105 mole) of trimethyl phosphite in one portion. The reaction temperature increased slightly from 25"C to 27"C. The clear colorless solution was aged at 20-25"C for 18 hours.
Once the formation of the acyl phosphonate was complete, the solution was used without purification for the next reaction in the sequence, formation of the tetraalkyl bisphophonate ester. The acyl phosphonate was isolated as a crystalline solid by concentrating in vacuo to almost dryness, adding hexanes and filtering, MP 60-63"C.
Anal. Calcd. For C14H16NO6P: C, 51.69; H, 4.92; N, 4.30; P, 9.53; Found: C, 51.27; H, 4.93; N, 4.25; P, 9.31.
Step 4: Preparation of Tetramethyl Phthalimido 1-Hydroxybutylidene)bisphosphonate (4) The toluene solution from Step3 containing a theoretical 32.5 g (0.1 mole) of the acyl phosphonate was used without purification for formation of the tetraalkyl bisphophonate ester. To the solution stirred at 20-25"C under nitrogen was added dimethyl phosphite, 11.6 g (0.105 mole) in one portion. Triethylamine, 10.0 g (0.1 mole) was added dropwise over 15 minutes while maintaining a reaction temperature of 20-25"C with external cooling. During the addition of the triethylamine there was a rapid crystallization of the bisphosphonate resulting in a thick slurry. The slurry was stirred at 20-25"C for an additional 1 hour.
The reaction mixture was cooled to 0-5"C, aged for 1 hour then filtered. The cake was washed with 50 ml of toluene and the product dried in vacuo (house vacuum) at 40"C to constant weight yielding 40.0 g (92%) of white crystalline bisphosphonate, MP 140-143"C.
Anal. Calcd. For C16H23N09P2: C, 44.14; H, 5.28; N, 3.21; P, 14.24; Found: C, 44.10; H, 5.23; N, 3.09; P, 14.20.
StepS: Preparation of (4-Amino-l-Hydroxybutylidene) Bisphosphonic Acid (ABP) (5) Tetramethyl-l,l-bisphosphono-l-hydroxy-4 phthalinidobutane 40 g (0.091 mole) from Step 4 was dissolved in 200 ml of 6N HC1 and the solution refluxed for 18 hours.
The resulting suspension was cooled to 0-5"C and the phthalic acid was removed by filtration. The phthalic acid cake was washed with 50 ml of 6 N HC1 and the combined filtrate concentrated to 25 ml then flushed with an additional 50 ml of water. The solution was cooled to 20-25"C during which time the ABP crystallizes. The crystallization was completed by adding 75 ml of 95% ethanol.
The suspension was cooled to 0-5"C and aged at that temperature for 2 hours. The titled product was collected by filtration and washed with 25 ml of 95% ethanol. The yield was 24.0 g (97.8%, but 89.8% based on starting GABA) after air drying to constant weight.
Step 6: Preparation of (4-Amino-l-Hydroxy butylidene)-Bisphosphonic Acid Monosodium Salt Trihydrate (6) Ten grams (37.4 mmol) of (4-amino-lhydroxybutylidene)biphosphonic acid, (ABP) was suspended in 300 mL of distilled deionized water with vigorous stirring at 25"C. The pH was 2.27 and was titrated to pH 4.3 to 4.4 by the gradual addition of 7.5 ml (37.4 mmol) 5N sodium hydroxide solution, resulting in a clear solution.
The clear solution was filtered through a medium sintered-glass funnel to remove any insoluble material. Twenty percent of the filtrate (-60 mL) was addedover 5 minutes to 40G mL of 95% ethanol at 20-250C with vigorus stirring and aged for one hour.
The remaining 240 mL of aqueous solution was added over 15 minutes and the mixture aged for 2 hours at 20-25 C. The white sodium salt was collected by filtration, washed with 100 ml of 2:1 EtOH:H2O and air dried at 40"C to yield 11.25 g (93%) of mono sodium salt trihydrate.

Claims (10)

WHAT IS CLAIMED IS:
1. A process for producing omega-amino-l hydroxy-C2-C6-alkylidene-bisphosphonic acid comprising the steps of: (a) contacting omega-phthalimido-C2-C6alkanoyl chloride with tri C1-C4 alkyl phosphite in a dry inert organic solvent at a temperature in the range of O to 60"C to form di C1-C4 alkyl omegaphthalimido-C2-C6-alkanoyl phosphonate; (b) contacting di C1-C4 alkyl omegaphthalimido-C2-C6-alkanoyl phosphonate from Step (a) with di C1-C4 alkyl phosphite in a dry inert organic solvent in the temperature range of O to 60"C to form tetra C1-C4 alkyl omega-phthalimido-l-hydroxy C2-C6-alkylidene-bisphosphonate;; (c) contacting tetra C1-C4 alkyl omega phthalimido-l-hydroxy-C2-C6-alkylidene-bisphosphonate from Step (b) with aqueous strong acid at a temperature in the range of 90"C to reflux to form omega amino-l-hydroxy-C2-C6-alkylidene-bisphosphonic acid.
2. The process of Claim 1 wherein said alkanoyl chloride is derived from glycine, 3-aminopropanoic acid, 4-aminobutanoic acid, 5-aminopentanoic acid or 6-aminohexanoic acid.
3. The process of Claim 1 wherein the temperature range for Step (a) is in the range of 20 to 25"C.
4. The process of Claim 1 wherein the temperature range for Step (b) is in the range of 20 to 25"C.
5. The process of Claim 1 wherein the temperature for Step (c) is the reflux temperature of the solvent.
6. The process of Claim 1 wherein the solvent for Step (a) is selected from C6-C10 aromatic hydrocarbons, chlorinated C6-C10 aromatic hydrocarbons chlorinated C1-C4 alkyl hydrocarbons, C2-C3 alkylnitriles, C4-C6 linear or cyclic ethers.
7. The process of Claim 1 wherein the solvent for Step (b) is the same as for Step (a).
8. The process of Claim wherein the strong acid in Step (c) is aqueous hydrochloric acid.
9. The process of Claim 1 wherein the product phosphonate from Step (a) is not isolated prior to conducting Step (b).
10. A process for producing 4-amino-lhydroxybutylidene-bisphosphonic acid comprising the steps of: (a) contacting 4-phthalimidobutanoyl chloride with trimethyl phosphite in a dry inert organic solvent at a temperature in the range of 0 to 60 C to form dimethyl 4-phthalimidobutanoyl phosphonate; (b) contacting dimethyl 4-phthalimidobutanoyl phosphonate from Step (a) with dimethylphosphite in a dry inert organic solvent in the temperature range of O" to 60"C to form tetramethyl phthalimido-1-hydroxybutylidene-bisphosphonate; ; (c) contacting tetramethyl phthalimidol-hydroxybutylidene-bisphosphonate from Step (b) with aqueous hydrochloric acid at a temperature in the range of 800C to reflux to form 4-amino-1-hydroxybutylidene-bisphosphonic acid.
GB9119201A 1990-09-18 1991-09-09 Amino-hydroxy-alkylidene bis phosphonic acids Withdrawn GB2248061A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58431890A 1990-09-18 1990-09-18

Publications (2)

Publication Number Publication Date
GB9119201D0 GB9119201D0 (en) 1991-10-23
GB2248061A true GB2248061A (en) 1992-03-25

Family

ID=24336831

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9119201A Withdrawn GB2248061A (en) 1990-09-18 1991-09-09 Amino-hydroxy-alkylidene bis phosphonic acids

Country Status (1)

Country Link
GB (1) GB2248061A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996033199A1 (en) * 1995-04-20 1996-10-24 Merck & Co., Inc. Process for making 1-hydroxybisphosphonates
EP0847991A1 (en) * 1996-12-16 1998-06-17 Dainippon Ink And Chemicals, Inc. Method for the preparation of N-(carboxyalkyl) imides
AU704419B2 (en) * 1995-04-21 1999-04-22 Sumitomo Rubber Industries, Ltd. Golf ball having two-layer cover structure
WO2001010874A1 (en) * 1999-08-06 2001-02-15 Medichem S.A. Process for producing 4-amino-1-hidroxybutylidene-1,1-bisphosphonic acid and its trihydrated monosodic salt

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0039033A1 (en) * 1980-04-28 1981-11-04 Henkel Kommanditgesellschaft auf Aktien Process for preparing omega-amino-1-hydroxyalkylidene-1, 1-bis phosphonic acids
GB2118042A (en) * 1982-04-15 1983-10-26 Gentili Ist Spa Pharmaceutical compositions containing biphosphonic acids

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0039033A1 (en) * 1980-04-28 1981-11-04 Henkel Kommanditgesellschaft auf Aktien Process for preparing omega-amino-1-hydroxyalkylidene-1, 1-bis phosphonic acids
GB2118042A (en) * 1982-04-15 1983-10-26 Gentili Ist Spa Pharmaceutical compositions containing biphosphonic acids

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Phosphorus, Sulphur Silicon Relat. Elem, 42 (1-2) 73-83 (1989) *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996033199A1 (en) * 1995-04-20 1996-10-24 Merck & Co., Inc. Process for making 1-hydroxybisphosphonates
AU704419B2 (en) * 1995-04-21 1999-04-22 Sumitomo Rubber Industries, Ltd. Golf ball having two-layer cover structure
EP0847991A1 (en) * 1996-12-16 1998-06-17 Dainippon Ink And Chemicals, Inc. Method for the preparation of N-(carboxyalkyl) imides
WO2001010874A1 (en) * 1999-08-06 2001-02-15 Medichem S.A. Process for producing 4-amino-1-hidroxybutylidene-1,1-bisphosphonic acid and its trihydrated monosodic salt
ES2153794A1 (en) * 1999-08-06 2001-03-01 Medichem Sa Process for producing 4-amino-1-hidroxybutylidene-1,1-bisphosphonic acid and its trihydrated monosodic salt
US6573401B1 (en) 1999-08-06 2003-06-03 Medichem, S.A. Process for producing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid and its trihydrated monosodium salt

Also Published As

Publication number Publication date
GB9119201D0 (en) 1991-10-23

Similar Documents

Publication Publication Date Title
US5159108A (en) Process for preparing an antihypercalcemic agent
JP2563954B2 (en) 1-Hydroxy-3- (N-methyl-N-propylamino) propane-1,1-diphosphonic acid and therapeutic agent for calcium metabolism disorder containing this compound
US5039819A (en) Diphosphonate intermediate for preparing an antihypercalcemic agent
EP0971938B1 (en) Process for the production of 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof
DK149609B (en) METHOD OF ANALOGUE FOR THE PREPARATION OF HYDROXYAMINO-ALKAN OR ALKENPHOSPHONIC ACID DERIVATIVES OR ESTERS OR SALTS THEREOF
US6600068B2 (en) Process for preparing ethanebis(methylphosphinic) acid
EP1390373B9 (en) Process for the preparation of 4-amino-1-hydroxybutylidene-1, 1-biphosphonic acid
FI83421B (en) FOERFARANDE FOER FRAMSTAELLNING AV FARMAKOLOGISKT ANVAENDBARA METYLENBISFOSFONSYRADERIVAT.
GB2248061A (en) Amino-hydroxy-alkylidene bis phosphonic acids
GB2248063A (en) Phthalimido alkanoyl phosphonates
US5099056A (en) Process for the production of n-substituted-aminomethylphosphonic acid dialkylesters and of the corresponding acids
JP4465153B2 (en) Method for preparing 1-hydroxy-1,1-diphosphonic acid compound
IE912920A1 (en) Process for the preparation of aminomethylphosphonic acid¹and aminomethylphosphinic acids
PL174910B1 (en) Method of obtaining aminomethanophosphonic acid
US4948918A (en) Process for the preparation of α-aminoalkylphosphonic acids
US6284909B1 (en) Preparations of thiophosphites and thiophosphonates
JPH0141639B2 (en)
US20040236144A1 (en) Method for producing $g(a)-aminophosphonic acids
EP0104775A1 (en) Production of N-phosphonomethylglycine
EP1000072B1 (en) Process for the preparation of [2-((8,9)- dioxo-2,6-diazabicyclo [5.2.0]-non-1(7)-en-2-yl)-ethyl] phosphonic acid
JPS63122694A (en) Production of 2-amino-4-phosphinyl butanoic acid
EP0451596B1 (en) Phosphonylation process
HU187797B (en) Process for production of amino-methyl-phosphonic acid
IE912921A1 (en) Process for the preparation of aminomethylphosphonic acid¹and aminomethylphosphinic acids from N-hydroxymethylamides
JPS6058996A (en) Manufacture of phosphonomethylated amino acid

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)